As of January 22, 2025, Corbus Pharmaceuticals (CRBP) has a market cap of $0.14 billion USD. According to our data, Corbus Pharmaceuticals is ranked No.7442 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.14 B |
-3.81%
|
Dec 31, 2024 | $0.14 B |
95.36%
|
Dec 29, 2023 | $73.56 M |
81.38%
|
Dec 30, 2022 | $40.56 M |
-81.98%
|
Dec 31, 2021 | $0.23 B |
-50.72%
|
Dec 31, 2020 | $0.46 B |
-77.11%
|
Dec 31, 2019 | $2.00 B |
-6.51%
|
Dec 31, 2018 | $2.13 B |
-17.75%
|
Dec 29, 2017 | $2.59 B |
-15.98%
|
Dec 30, 2016 | $3.09 B |
412.12%
|
Dec 31, 2015 | $0.60 B |
-44.82%
|
Dec 31, 2014 | $1.09 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
FibroGen
FGEN
|
$50.79 M |
0.000 M
|
USA
|
Galapagos NV
GLPG
|
$1.58 B |
0.000 M
|
Belgium
|
Cytokinetics
CYTK
|
$5.53 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Market Cap | = | CRBP Stock Price | * | CRBP Shares Outstanding |
= | $11.35 | * | 12.18 M | |
= | $0.14 B |